Maintains strong balance sheet with EUR 18.5 million ( USD 20.3 million ) in cash as of March 31, 2020 Signs exclusive worldwide distribution agreement with Exact Imaging to combine their innovative micro-ultrasound technology with Focal One to offer an end-to-end focal therapy solution for the
Exact Imaging is a leading developer of ultra-high-resolution micro-ultrasound diagnostic technologies Micro-ultrasound ExactVu™ is the only ultrasound-based imaging tool with published data demonstrating prostate cancer diagnostic capabilities similar to MRI Combination of Exact Imaging’s
Company to host conference call and webcast on Thursday, May 14 at 8:30 am EDT LYON, France , May 6, 2020 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the first quarter ended March 31, 2020 after the
Record full year 2019 revenues of €44.9 million, representing 14.6% year-over-year growth HIFU full year 2019 revenue growth of 28% driven by 54% growth in US installed base Record 46.8% gross profit margin driven by HIFU growth Profitable for the full year 2019 with operating income of €2.2
Company to host conference call and webcast on Tuesday, March 31 st @ 8:30 am EDT LYON, France , March 24, 2020 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the fourth quarter and year ended
LYON, France , March 17, 2020 – EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today issued the following letter to shareholders: To my fellow shareholders, The COVID-19 virus represents a new challenge for us all, and I want to formally update
LYON, France , February 18, 2020 – EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that the company recently showcased its Focal One high intensity focused ultrasound (HIFU) device at the 12 th International Symposium on Focal Therapy
University of Miami Sylvester Comprehensive Cancer Center , a Long-Time EDAP Ablatherm® User, to Upgrade to the Most Advanced HIFU Technology for the Treatment of Prostate Disease Focal One Successfully Launched with Several Patients Treated to Date LYON, France , January 29, 2020 – EDAP TMS SA
Recaps significant progress made in 2019 and previews expectations for accelerating global growth in 2020 LYON, France , January 9, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in Robotic Energy-based Therapies, today issued the following letter to shareholders: To my
Study confirms feasibility of using Focal One HIFU to treat rectal endometriosis LYON, France , December 19, 2019 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in therapeutic ultrasound, today announced that Focal One data has been accepted for publication in the journal of
